Model selection and scaling

Animal Models in Toxicology, Second Edition

Volumn , Issue , 2006, Pages 831-861

  Gad, Shayne C ^a  

^a American College of Toxicology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123396555     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (101)

1. Alcock, S. J. (1971). An anti-inflammatory compound: Non-toxic to animals, but with an adverse action in man. Proc. Eur. Soc. Stud. Drug Tox. 12, 184-190.
2. Anderson, P. D., and Weber, L. J. (1975). Toxic response as a quantitative function of body size. Toxicol. Appl. Pharmacol. 33, 471-481.
3. Angel, G. (1969). Starvation, stress and the blood brain barrier. Dis. Nerv. Syst. 30, 94-97.
4. Angervall, L., and Carlstrom, E. (1963). Theoretical criteria for the use of relative organ weights and similar ratios in biology. J. Theoret. Biol. 4, 254-259.
5. Animal Clinical Chemistry Association. (1988). Assessment of hepatic function and damage in animal species. J. Appl. Toxicol. 8, 249-254.
6. Bartek, M. J., LaBudde, I. A., and Maibach, H. I. (1972). Skin permeability in vivo: Comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 58, 114-123.
7. Benedict, F. C. (1938). Vita energetics: A study in comparative basal metabolism. Washington, DC: Carnegie Institute.
8. Borzelleca, J. F. (1984). Extrapolation of animal data to man. In Concepts in toxicology (Vol. I), ed. A. S. Tegeris, 294-304. New York: Karger.
9. Boxenbaum, H. (1982). Interspecies scaling, allometry, physiological time and the ground plan of pharmaco-kinetics. J. Pharmacokinet. Biopharmacol. 10, 201-227.
10. Boxenbaum, H., and DiLea, C. (1995). First-time-in-human dose selection: Allometric throughs and perspectives. J. Clin. Pharm. 35, 957-966.
11. Boyd, E. M., Dodos, L., and Krijnen, C. J. (1970). Endosulfan toxicity and dietary protein. Arch. Environ. Health. 21, 15-19.
12. Boyd, M. R., Wilson, B. J., Harris, T. M. (1972). Confirmation by chemical synthesis of the structure of 4-ipomeanol, a lung toxic metabolite of the sweet potato, Ipomoea batatas. Nat. New Biol. 236(66) 158-159.
13. Brown, S. L., Brett, S. M., Gough M., Radricks, J. V., Tardiff, R. C., and Turnball, D. (1988). Review of interspecies risk comparisons. Reg. Toxicol. Pharmacol. 8, 191-206.
14. Brown, V. K. (1980). Acute toxicity in theory and practice. New York: Wiley.
15. Bruce, R. D. (1985). An up-and-down procedure for acute toxicity testing. Fund. Appl. Toxicol. 5, 151-157.
16. Brus, R., and Herman, Z. S. (1971). Acute toxicities of adrenaline, noradrenaline and cetylcholine in adult and neo-natal mice. Dissert. Pharm. Pharmacol. 23, 435-437.
17. Calabrese, E. J. (1983). Principles of animal extrapolation. New York: Wiley.
18. Campbell, R. L., and Bruce, R. D. (1981). Comparative dermatotoxicology. Toxicol. Appl. Pharmacol. 59, 555-563.
19. Clayson, D. B. (1988). Needs for biological risks assessment in interspecies extrapolation. Environ. Health Perspect. 77, 93-97.
20. Dauterman, W. C. (1980). Physiological factors affecting metabolism of xenobiotics. In Introduction to biochemical toxicology, eds. E. Hodgeson and F. E. Guthrie, 287-312. New York: Elsevier.
21. Davidson, I. W. F., Parker, J. C., and Beliles, R. P. (1986). Biological basis for extrapolation across animal species. Regul. Toxicol. Pharmacol. 6, 211-237.
22. Dawson, M. L., and Stara, J. F. (1983). Regulatory history and experimental support of uncertainly (safety) factors Reg. Toxicol. Pharmacol. 3, 224-238.
23. Depass, L. R., Myers, R. C., Weaver, E. V., and Weil, C. S. (1984). Alternative methods in toxicology: Vol. 2. Acute toxicity testing. New York: Mary Ann Liebert.
24. Dixon, R. L. (1976). Problems in extrapolating toxicity data from laboratory animals to man. Environ. Health Perspect. 13, 43-50.
25. Doull, J. (1980). Factors influencing toxicology. In Casarett and Doull's toxicology, eds. J. Doull, C. D. Klaassen, and M. O. Amdur, 341-362. New York: Macmillan.
26. Eben, A., and Pilz, W. (1967). Abhangigbeit der Acetylcholinesterase-acktivata in Plasma and Erythrocyten von der alter and geschlecht der Ratte. Arch. Toxicol. 23, 27-34.
27. Ehrich, M., and Gross, W. B. (1983). Modification of triorthotolyl phosphate toxicity in chickens by stress. Toxicol. Appl. Pharmacol. 70, 249-254.
28. Fara, J. W., Anderson, L. D., Casper, A. C. T., and Myrback, R. E. (1988). Assessment and validation of animal models to evaluate topical effects of substances on gastrointestinal mucosa. Pharmaceut. Res. 5, 165-170.
29. FDA. (2002). Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Washington, DC: U.S. Department of Health and Human Services.
30. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E. (1966). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother. Rep. 50, 219-244.
31. Gad, S. C., and Chengelis, C. P. (1998). Acute toxicology: Principles and methods (2nd ed.). San Diego, CA: Academic Press.
32. Gad, S. C., Smith, A. C., Cramp, A. L., Gavigan, F. A., and Derelanko, M. J. (1984). Innovative designs and practices for acute systemic toxicity studies. Drug Chem. Toxicol. 7, 423-434.
33. Gad, S. C., and Weil, C. S. (1980). Statistical analysis of body weight: A reply. Toxicol. Appl. Pharmacol. 57, 335-337.
34. Gaines, T. B. (1960). The acute toxicology of pesticides to rats. Toxicol. Appl. Pharmacol. 2, 88-99.
35. Gaines, T. B. (1969). Acute toxicology of pesticides. Toxicol. Appl. Pharmacol. 14, 515-534.
36. Garattini, S. (1985). Toxic effects of chemicals: Difficulties in extrapolating data from animals to man. Crit. Rev. Toxicol. 16, 1-29.
37. Geary, R. S., Leeds, J. M., Henry, S. P., Monteith, D. K., and Levin, A. A. (1997). Antisense oligonucleotide inhibitors for the treatment of cancer: 1. QUESTION Pharmacokinetic properties of phosporothioate oligodeoxynucleotides. Anti-Cancer Drug Des. 12, 383-393.
38. Gibson, J. E., and Starr, T. B. (1988). Opportunities for improving techniques for interspecies extrapolation in the risk assessment process. Environ. Health Perspect. 77, 99-105.
39. Gillette, J. R. (1979). Extrapolating from microsomes to mice to men. Drug Metab. Dispos. 7, 121-123.
40. Gingell, R., and Wallcave, L. (1974). Species differences in the acute toxicity and tissue distribution of DDT in mice and hamsters. Toxicol. Appl. Pharmacol. 28, 385-394.
41. Goldenthal, E. I. (1971). A compilation of LDP values in newborn and adult animals. Toxicol. Appl. Pharmacol. 18, 185-207.
42. Gralla, E. J. (1986). Species-specific toxicoses with some underlying mechanisms. In Safety evaluation of drugs and chemicals, ed. W. E. Lloyd, 55-81. New York: Hemisphere.
43. Gray, H., and Addis, T. (1948). Rat colony testing by Zucker's weight-age relation. Am. J. Physiol. 153, 350.
44. Gregory, A. R. (1988). Species comparison in evaluating carcinogenicity in humans. Reg. Toxicol. Pharmacol. 8, 160-190.
45. Halberg, F., Johnson, E. A., Brown, B. W., and Bittner, J. J. (1960). Susceptibility rhythm to E. coli endotoxin and bioassay. Proc. Soc. Exp. Biol. Med. 103, 142-144.
46. Hawkins, D. R., and Chasseaud, C. F. (1985). Reasons for monitoring kinetics in safety evaluation studies. Arch. Toxicol. 8(Suppl.), 165-172.
47. Hottendorf, G. H. (1987). Species differences in toxic lesions. In Human risk assessment, ed. M. V. Roloff, 87-95. Philadelphia: Taylor & Francis.
48. Hudson, R. H., Haegele, M. A., and Tucker, R. K. (1979). Acute oral and percutaneous toxicity of pesticides to mallards: Correlations with mammalian toxicity data. Toxicol. Appl. Pharmacol. 47, 451-460.
49. Johnson, E. M. (1988). Cross-species extrapolations and the biologic basis for safety factor determinations in developmental toxicology. Reg. Toxicol. Pharmacol. 8, 22-36.
50. Johnson, H. D., and Voss, E. (1952). Toxicological studies of zinc phosphide. J. Am. Pharm. Assoc. (Sci. Ed.). 41, 468-472.
51. Kato, R., and Gillette, J. R. (1965). Sex difference in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes. J. Pharmacol. Exp. Ther. 150, 285-291.
52. Kling, T. G., and Long, K. R. (1969). Blood cholmesterase in previously stressed animals subjected to parathoin. J. Occup. Med. 11, 82-84.
53. Krasovskij, G. N. (1975). Species and sex differences in sensitivity to toxic substances. In Methods used in the USSR for establishing biologically safe levels of toxic substances, 109-125. Geneva: World Health Organization.
54. Lehman, A. J. (1959). Some relations of drug toxicities in experimental animals compared to man. In Appraisal of safety of chemicals in foods, drugs and cosmetics. Association of Food and Drug Officials of the United States.
55. Lenox, R. H., and Frazier, T. W. (1972). Methadone induced mortality as a function of the circadian cycle. Nature. 239, 397-398.
56. Lijinsky, W. (1988). Importance of animal experiments in carcinogenesis research. Environ. Mol. Mutagen. 11, 307-314.
57. Litchfield, J. T. (1961). Forecasting drug effects in man from studies in laboratory animals. J. Am. Med. Soc. 177, 34.
58. Litchfield, J. T. (1962). Symposium on clinical drug evaluation and human pharmacology. Clin. Pharmacol. Ther. 3, 665-672.
59. Lutzen, L., Trieb, G., and Pappritz, G. (1976). Allometric analysis of organ weights: II. Beagle dogs. Toxicol. Appl. Pharmacol. 35, 543-551.
60. Mahmood, I. (2004). Interspecies pharmacokinetic scaling: Principles, applications and limitations. In Pharmacokinetics in drug development (Vol. 1), eds. P. Bonate and D. Howard, 423-444. Arlington, VA: AAPS Press.
61. Maines, M. D., and Westfall, B. A. (1971). Sex difference in the metabolism of hexobarbital in the Mongolian gerbil. Proc. Soc. Exp. Biol. Med. 138, 820-822.
62. Mann, D. E. (1965). Biological aging and its modification of drug activity. J. Pharm. Sci. 54(4), 499-510.
63. Mattfeldt, T., and Mall, G. (1987). Statistical methods for growth allometric studies. Growth. 51, 86-102.
64. Mehrle, P. M., and DeClue, M. E. (1973). Phenylalanine determination in fish serum: Adaptation of a mammalian method to fish. Anal. Biochem. 52(2), 660-661.
65. Naik, S. R., Anjaria, R. J., and Sheth, U. K. (1970). Studies on rat brain acetylcholine and cholinesterase: Part 1. Effect of body weight, sex, stress and CNS depressant drugs. Ind. J. Med. Res. 58, 473-479.
66. Natelson, B. H., Hoffman, S. L., and Cagin, N. A. (1979). A role for environmental factors in the production of digitalis toxicity. Pharmacol. Biochem. Behav. 12, 235-237.
67. National Academy of Sciences. (1975). Experiments and research with humans: Values in conflict (Academy Forum, 3rd in series). Washington, DC: National Academy of Sciences.
68. Nixon, G. A., Tyson, C. A., and Wertz, W. C. (1975). Interspecies comparisons of skin irritancy. Toxicol. Appl. Pharmacol. 31, 481-490.
69. Nosal, M., and Hladka, A. (1968). Determination of the exposure to fenitrothion on the basis of the excretion of p-vitro-m-cresol by the urine of persons tested. Arch. Gewerbepath. Gewerbehyg. 25, 28-38.
70. Oser, B. L. (1981). The rat as a model for human toxicology evaluation, J. Toxicol. Environ. Health. 8, 521-542.
71. Otterness, I. G., and Gans, D. J. (1988). Nonsteroidal anti-inflammatory drugs: An analysis of the relationship between laboratory animals and clinical doses, including species scaling. J. Pharm. Sci. 77, 790-795.
72. Pallotta, A. J., Kelly, M. G., Rall, D. P., and Ward, J. W. (1962). Toxicology of acetoxycycloheximide as a function of sex and body weight. J. Pharmacol. Exp. Ther. 136, 400-405.
73. Pinkel, D. (1958). The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Res. 18, 853-856.
74. Plaa, G. L. (1976). Animal models in the safety evaluation process. Austral. J. Pharm. Sci. NSS, 57-63.
75. Quinn, G. P., Axelrod, J., and Brodie, B. B. (1958). Species, strain and sex differences in metabolism of hexobarbitone aminopyrine antipyrine and aniline. Biochem. Pharmacol. 1, 152-159.
76. Rall, D. P. (1979). Relevance of animal experiments to humans. Environ. Health Perspect. 32, 297-300.
77. Rider, J. A., Mueller, H. C., Puletti, E. J., and Swader, J. I. (1969). Toxicity of parathion, systox, octamethyl pyrophosphoramide and methyl parathion in man. Toxicol. Appl. Pharmacol. 14, 603-611.
78. Rothschild, L. (1961). A classification of living animals. London: Longman.
79. Safarov, Y. B. and Aleskerov, S. A. (1972). Effects of pesticides in producing relapses in animals recovering from bacterial infections. Probl. Vet. Sanit. 43, 213-218.
80. Schein, P. S., Davis, R. D., Carter, S., Newman, J., Schein, D. R., and Rall, D. P. (1970). The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin. Pharmaco. Ther. 11, 3-40.
81. Scheving, L. E., Mayerbach, H. V., and Pauly, J. E. (1974). An overview of chronopharmacology. J. Eur. Toxicol. 7, 203-227.
82. Schmidt-Nielsen, K. (1984). Scaling: Why is animal size so important? New York: Cambridge University Press.
83. Schneiderman, M. A., Mantel, N., and Brown, C. C. (1975). From mouse to man-or how to get from the laboratory to Park avenue and 59th street. Ann. NY Acad. Sci. 246, 237-248.
84. Shanor, S. P., van Hees, G. R., Baart, N., Erdos, E. G., and Foldes, E. F. (1961). The influence of age and sex on human plasma and red cell cholinesterase. Am. J. Med. Sci. 242, 357-361.
85. Slaga, J. J. (1988). Interspecies comparisons of tissue DNA damage, repair, fixation, and replication. Environ. Health Perspect. 77, 73-82.
86. Spector, W. S. (1956). Handbook of biological data. Philadelphia: Saunders.
87. Steen, J. A., Hanneman, G. D., Nelson, P. L., and Folk, E. D. (1976). Acute toxicity of mevinophos to gerbils. Toxicol. Appl. Pharmacol. 35, 195-198.
88. Stevenson, D. E. (1979). Current problems in the choice of animals for toxicity studies. J. Toxicol. Environ. Health. 5, 9-15.
89. Stockinger, H. E. (1953). Size of dose: Its effect on distribution in the body. Nucleonics. 11, 24-27.
90. Trieb, G., Pappritz, G., and Lutzen, L. (1976). Allometric analysis of organ weights: I. Rats. Toxicol. Appl. Pharmacol. 35, 531-542.
91. Vaccarezza, J. R., and Peltz, L. (1960). Effect of ACTH on blood cholinesterase activity in normal subjects and respiratory-allergy patients. Presse Med. 68, 723-724.
92. Vaccarezza, J. R., and Willson, J. A. (1964a). The effect of ACTH on cholinesterase activity in plasma, whole blood and blood cells of rats. Experientia. 20, 23.
93. Vaccarezza, J. R., and Willson, J. A. (1964b). The relationship between corticosterone administration and cholinesterase activity in rats. Experientia. 21, 205.
94. Vessell, E. S. (1968). Genetic and environmental factors affecting hexobarbital metabolism in mice. Ann NY Acad. Sci. 151, 900-912.
95. Visek, W. J. (1988). Issues and current applications of interspecies extrapolation of carcinogenic potency as a component of risk assessment. Environ. Health Perspect. 77, 49-54.
96. Vogel, W. H. (1987). Stress: The neglected variable in experimental pharmacology and toxicology. Trends Pharmacol. Sci. 7, 35-37.
97. Weil, C. S. (1972). Guidelines for experiments of predicting the degree of safety of a material for man. Toxicol. Appl. Pharmacol. 21, 194-199.
98. Weil, C. S., and Gad, S. C. (1980). Applications of methods of statistical analysis to efficient repeated dose toxicology tests 2. Powerful methods for analysis of body liver and kidney weight data. Tox. Appl. Pharmacol. 52, 214-226.
99. Yates, F. E., and Kugler, P. N. (1986) Similarity rinciples and intrinsic geometrics: Contrasting approaches to interspecies scaling. J. Pharm. Sci. 75(11), 1019-1027.
100. Zbinden, G. (1988). Reduction and replacement of laboratory animals in toxicological testing and research. Interim report 1984-1987. Biomed. Environ. Sci. 1(1), 90-100.
101. Zbinden, G., and Bagdon, R. E. (1963). Isoproterenol-induced heart necrosis and experimental model for the study of angina pectoris and myocardial infarct. Rev. Canada Biol. 22, 257-263.